In their work, Harroud et al. [4] concluded that rs10191329 regulates the expression of two candidate target genes, namely ZNF638 and DYSF, which possibly shape the levels of “neurocognitive reserve” and CNS “tissue resilience” in MS patients. This evidence concerns the gene DYSF and myeloid sarcoma.